Medelis competitorsClear all

Medelis's top competitors include ImmunoGen, Aeglea Biotherapeutics, XBiotech and ProQinase.
Medelis
Medelis
Medelis is a specialty oncology contract research organization focused on preclinical and phase 1 through phase 3 oncology trials.
ImmunoGen
ImmunoGen
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
XBiotech
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
ProQinase
ProQinase
ProQinase is a contract research organization for drug discovery in oncology.
Founding Date
Founding Date
2003
Founding Date
1981
Founding Date
2013
Founding Date
2005
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Nashville, US HQ
Locations
Waltham, US HQ
Brentwood, US
Locations
Austin, US HQ
Austin, US
Locations
Austin, US HQ
Locations
Freiburg im Breisgau, DE HQ
Employees
Employees
28
Employees
7575% decrease
Employees
761% increase
Employees
603% increase
Employees
20
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.5 b
Valuation ($)
356.7 m
Valuation ($)
496 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.6 k
Twitter followers
914
Twitter followers
N/A
Twitter followers
261
Twitter followers
83
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.1
Average likes per tweet (last 30 days)
6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
10%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
198850
Alexa Website Rank
317275
Alexa Website Rank
401753
Alexa Website Rank
267939
Alexa Website Rank
372752
Employee Rating
Employee Rating
1.2
Employee Rating
2.8
Employee Rating
4.3
Employee Rating
3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$82.3m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($104.1m) (FY, 2019)
Net income
($78.3m) (FY, 2019)
Net income
$668.6m (FY, 2019)
Net income
N/A
For sources of this data, please see the company profile

View company profiles

ImmunoGen
HQ
Waltham, US
Employees
75

ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
76↑ 1% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
XBiotech
HQ
Austin, US
Employees
60↑ 3% increase

XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.

View company
ProQinase
HQ
Freiburg im Breisgau, DE

ProQinase is a contract research organization for drug discovery in oncology.

View company